Connect with us

Hi, what are you looking for?

Investing

AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the primary objective in a...

Investing

Investor Insight Syntholene offers investors exposure to a first‑of‑its‑kind, publicly traded pure‑play synthetic fuel company positioned to disrupt a multi‑trillion‑dollar liquid fuels market with...